Navigation Links
Hospira Reports Fourth-Quarter and Full-Year 2012 Results
Date:2/13/2013

usted financial measures (3)$
,445.9$
455.6$
333.3$
2.01GAAP results for the year ended December 31, 2012 include:(A)

Facilities Optimization charges: $18.6 million reported in Restructuring, impairment, and (gain) disposition of assets, net.  The equipment and facility impairment charges relate to Hospira's plans to exit a specialty injectable drug finishing operation.(B)

Amortization of certain intangible assets reported in Cost of products sold resulting from acquisitions including Mayne Pharma, Javelin Pharma and a generic injectable business by Hospira India.(C)

Impairment of certain assets: $14.0 million reported in Restructuring, impairment, and (gain) on disposition of assets, net, and $10.1 million reported in Other expense (income), net. These charges relate to impairments of certain intangible assets and various investments, respectively.(D)

Certain quality and product related charges reported in Cost of products sold primarily include third party oversight and consulting costs, extended production downtime related costs, failure to supply penalties, device product review and remediation costs to address identified issues, and costs for corrective actions including product recalls and life-cycle management programs. These charges are primarily associated with Hospira's response to the FDA warning letters and charges related to certain device related remediation activities.(E)

Capacity expansion related charges report
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Hospira to Present at Upcoming Investor Conferences
2. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
3. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
4. Hospira Reports Third-Quarter 2012 Results
5. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
6. Hospira Reports Second-Quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira to Host Conference Call for Second-quarter 2012 Results
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
11. Hospira to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... SAN DIEGO , May 6, 2015  Mirati ... financial results for the first quarter ended March 31, ... programs. "We continue to make progress ... M. Baum , M.D., Ph.D., president and CEO, Mirati. ... at the upcoming American Society of Clinical Oncology meeting ...
(Date:5/6/2015)... -- Delcath Systems, Inc. (NASDAQ: DCTH ), a ... with an emphasis on the treatment of primary and ... months ended March 31, 2015.  Highlights ... , Achieved quarterly product revenue of $0.44 million, an ... quarter of 2014; , Activated a prospective patient ...
(Date:5/6/2015)... and influencers across North America have ... melanoma prevention begins with parents-encouraging everyone to create a #newfamilyrule ... , and parenting author Alyson Schafer are among ... to share this poignant video message: Click ... Melanoma Fund (DCMF)-producers of the viral video Dear ...
Breaking Medicine Technology:Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 2Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 4Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 5Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2
... MAQUET Cardiovascular LLC today announced the launch ... VASOSHIELD Pressure Controlling Syringe for use during Coronary Artery ... "flushing" pressure and controls vessel distension when harvested grafts ... Avoiding excessive pressure and limiting distension help maintain internal ...
... N.J. , May 3 Covance Inc. (NYSE: CVD ... Health Care Conference on Tuesday, May 4, 2010 at 1:30 ... www.covance.com .  In order to register and download any necessary software, please ... , Covance, ...
Cached Medicine Technology:MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 2MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 3MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 Qushanna Doby (20) ... a nearby drug treatment center in Florida while under the ... May 4th. New surveillance tapes released by CBS4’s Peter D’Oench ... her baby. Doby’s child is around one year old. The ... and shivering outside was not named. The residents polled by ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Corporate ... behalf of MEBC, an Alliance Award for excellence ... during FOCUS 2015, JDA’s annual user conference which ... retail and wholesale distribution sectors. This award recognizes ... are receiving services that advance their supply chain ...
(Date:5/6/2015)... May 06, 2015 The Canton Group is ... for the 6th annual charity softball game. The event ... & T Bank Stadium. Past years guests include Joe Flacco, ... are still on sale if you are interested ... local non-profit organizations, such as SOAR Baltimore and ...
(Date:5/6/2015)... Fla. (PRWEB) May 06, 2015 ... Institute are the first in north Florida and ... technology is the latest innovation in total hip ... highly advanced, surgeon-controlled robotic arm that enables the ... Medical Center Jacksonville has offered MAKOplasty® partial knee ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
Breaking Medicine News(10 mins):Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... go before they can claim to be new generation daddies, for only ... to a survey. ,The UK survey noted that 75 ... and 16 percent men argue every time over the issue. ... men argue about the job, it might help the couple to grow ...
... (RA) face different treatment options and determining which ones ... examined patients decisions regarding therapy for RA and glucosamine ... reluctant to change their treatment as long as their ... clinical trial results for glucosamine. ,Recent advances ...
... ability to walk. He and his mother feared that within ... a wheelchair. ,As is the case with more ... with few options and his family turned to Hospital for ... address his condition. ,They were introduced to David ...
... N.J., The European Commission granted marketing authorization ... atypical antipsychotic medication for the treatment ... designed to deliver paliperidone - the active ... osmotic delivery system (OROS(R)). ,In ...
... how gender affects learning have found that boys and ... different ways. ,However, they have suggested ... their kids from co-educational to segregated schools, or vice-versa. ... at Newcastle University in NSW, said that the key ...
... Scientists have achieved the first success in "decrypting" an enzyme's ... efficient route to drug discovery. ,Led by ... of Medicine, and Frank Raushel of Texas A and M, ... drug discovery, as many of the most successful drugs work ...
Cached Medicine News:Health News:Alternative Treatments for Arthritis 2Health News:Alternative Treatments for Arthritis 3Health News:Motion Analysis Helps Teen With Cerebral Palsy Regain Ability to Walk 2Health News:Motion Analysis Helps Teen With Cerebral Palsy Regain Ability to Walk 3Health News:INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia 2Health News:INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia 3Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:"Decryption" of Enzyme's Functions Paves Way for Future Drug Discovery 2
... and powerful Parisian Peel ESPRIT system encompasses ... for simplified skin care practice. , The ... meet strict medical device standards while offering ... a compact design. The ESPRIT offers ...
... high resolution optical coherence tonometry (OCT) retina ... It is based on the ... emerging from clinical research in the last ... and high resolution features enable the FD-OCT ...
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
The Clearview hCG Test is for the rapid detection of human chorionic gonadotropin (hCG) in urine specimens. This test kit is used to obtain a visual, qualitative result and is intended for professio...
Medicine Products: